» Articles » PMID: 20659573

Graft-versus-host Disease: Role of Inflammation in the Development of Chromosomal Abnormalities of Keratinocytes

Overview
Date 2010 Jul 28
PMID 20659573
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic stem cell transplantation. Squamous cell carcinoma (SCC) of the skin and mucous membranes are especially frequent in this setting where aneuploidy and tetraploidy are associated with aggressive disease. The current study is directed at the mechanism of neoplasia in this setting. Unmanipulated keratinocytes from areas of oral GVHD in 9 patients showed tetraploidy in 10% to 46% of cells when examined by florescein in situ hybridization (FISH). Keratinocytes isolated from biopsy sites of GVHD but not from normal tissue showed even greater numbers of tetraploid cells (mean = 78%, range: 15%-85%; N = 9) after culture. To mimic the inflammatory process in GVHD, allogeneic HLA-mismatched lymphocytes were mixed with normal keratinocytes. After 2 weeks, substantial numbers of aneuploid and tetraploid cells were evident in cultures with lymphocytes and with purified CD8 but not CD4 cells. Telomere length was substantially decreased in the lymphocyte-treated sample. No mutations were present in the p53 gene, although haploinsufficiency for p53 due to the loss of chromosome 17 was common in cells exposed to lymphocytes. These findings suggest that in GVHD, inflammation and repeated cell division correlate with the development of karyotypic abnormalities.

Citing Articles

Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil.

Gray A, Avila C, Chung C, Seminario-Vidal L, Mims A, Dulmage B JAAD Case Rep. 2023; 36:82-88.

PMID: 37250015 PMC: 10220457. DOI: 10.1016/j.jdcr.2023.03.023.


Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management.

Baumrin E, Loren A, Falk S, Mays J, Cowen E J Am Acad Dermatol. 2022; 90(1):19-36.

PMID: 36572064 PMC: 10287839. DOI: 10.1016/j.jaad.2022.12.023.


ASSESSMENT OF CYTOGENETIC DAMAGE TO EXFOLIATED GINGIVAL CELLS IN PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS.

Tadin A, Gavic L, Roguljic M, Babic M, Galic I, Zeljezic D Acta Clin Croat. 2021; 60(2):209-215.

PMID: 34744270 PMC: 8564832. DOI: 10.20471/acc.2021.60.02.06.


Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH).

Armenian S, Lindenfeld L, Iukuridze A, Echevarria M, Bebel S, Coleman C BMC Cancer. 2020; 20(1):721.

PMID: 32746799 PMC: 7397711. DOI: 10.1186/s12885-020-07232-2.


Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients.

Fantozzi P, Villa A, Antin J, Treister N Bone Marrow Transplant. 2020; 55(9):1844-1846.

PMID: 32273587 DOI: 10.1038/s41409-020-0889-2.


References
1.
Zhao L, Khan Z, HAYES K, GLASSMAN A . Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12. Ann Clin Lab Sci. 1998; 28(1):51-6. View

2.
West J, Ji C, Marnett L . Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1. J Biol Chem. 2005; 280(15):15141-7. DOI: 10.1074/jbc.M413147200. View

3.
Lalwani N, Dethloff L, Haskins J, Robertson D, de la Iglesia F . Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver. Toxicol Pathol. 1997; 25(2):165-76. DOI: 10.1177/019262339702500206. View

4.
Kammori M, Poon S, Nakamura K, Izumiyama N, Ishikawa N, Kobayashi M . Squamous cell carcinomas of the esophagus arise from a telomere-shortened epithelial field. Int J Mol Med. 2007; 20(6):793-9. View

5.
Hematti P, Sloand E, Carvallo C, Albert M, Yee C, Fuehrer M . Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation. Exp Hematol. 2002; 30(8):943-9. DOI: 10.1016/s0301-472x(02)00873-1. View